These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1911716)

  • 1. Interaction between variant apolipoproteins C-II and E that affects plasma lipoprotein concentrations.
    Hegele RA; Breckenridge WC; Cox DW; Maguire GF; Little JA; Connelly PW
    Arterioscler Thromb; 1991; 11(5):1303-9. PubMed ID: 1911716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of apolipoproteins E and C in type V hyperlipoproteinemia.
    Kuusi T; Taskinen MR; Solakivi T; Kauppinen-Mäkelin R
    J Lipid Res; 1988 Mar; 29(3):293-8. PubMed ID: 3379342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotien E polymorphism.
    St-Amand J; Moorjanit S; Lupien PJ; Prud'homme D; Després JP
    Metabolism; 1996 Feb; 45(2):261-7. PubMed ID: 8596500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency.
    Breckenridge WC; Alaupovic P; Cox DW; Little JA
    Atherosclerosis; 1982 Aug; 44(2):223-35. PubMed ID: 7138621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction.
    Hopkins PN; Wu LL; Schumacher MC; Emi M; Hegele RM; Hunt SC; Lalouel JM; Williams RR
    Arterioscler Thromb; 1991; 11(5):1137-46. PubMed ID: 1680391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal effects of apolipoprotein E alleles (epsilon 2 and epsilon 4) on plasma lipid levels in normolipidemic subjects.
    Eto M; Watanabe K; Ishii K
    Clin Genet; 1986 Jun; 29(6):477-84. PubMed ID: 3461894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypobetalipoproteinemia associated with apo B-48.4, a truncated protein only 14 amino acids longer than apo B-48.
    Ruotolo G; Zanelli T; Tettamanti C; Ragogna F; Parlavecchia M; Viganò F; Catapano AL
    Atherosclerosis; 1998 Mar; 137(1):125-31. PubMed ID: 9568744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
    Baroni MG; Berni A; Romeo S; Arca M; Tesorio T; Sorropago G; Di Mario U; Galton DJ
    BMC Med Genet; 2003 Sep; 4():8. PubMed ID: 12964943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins.
    Gómez-Coronado D; Alvarez JJ; Entrala A; Olmos JM; Herrera E; Lasunción MA
    Atherosclerosis; 1999 Nov; 147(1):167-76. PubMed ID: 10525138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotype.
    Luc G; Ducimetiere P; Bard JM; Arveiler D; Evans A; Cambien F; Fruchart JC; Fievet C
    Atherosclerosis; 1997 Jun; 131(2):257-62. PubMed ID: 9199280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.
    Ghiselli G; Schaefer EJ; Zech LA; Gregg RE; Brewer HB
    J Clin Invest; 1982 Aug; 70(2):474-7. PubMed ID: 7096573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.
    Brisson D; Ledoux K; Bossé Y; St-Pierre J; Julien P; Perron P; Hudson TJ; Vohl MC; Gaudet D
    Pharmacogenetics; 2002 Jun; 12(4):313-20. PubMed ID: 12042669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
    Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
    Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous apolipoprotein C-II deficiency: lipoprotein and apoprotein phenotype and RsaI restriction enzyme polymorphism in the Apo C-IIPadova kindred.
    Gabelli C; Bilato C; Santamarina-Fojo S; Martini S; Brewer HB; Crepaldi G; Baggio G
    Eur J Clin Invest; 1993 Sep; 23(9):522-8. PubMed ID: 7902280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
    Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
    Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.